Akifumi Morinaka
Director/Board Member at Rege Nephro Co. Ltd.
Profile
Akifumi Morinaka is currently working as an Outside Director at Rege Nephro Co. Ltd.
and as a Principal at JAFCO Group Co. Ltd.
(Private Equity) since 2019.
He previously worked as an Outside Director at Chordia Therapeutics, Inc.
Akifumi Morinaka active positions
Companies | Position | Start |
---|---|---|
JAFCO Group Co. Ltd. (Private Equity)
JAFCO Group Co. Ltd. (Private Equity) Investment ManagersFinance JAFCO Group Co. Ltd. (JAFCO Group) is the private equity arm of the parent firm, JAFCO (TSE: 8595), founded in 1973. The firm is headquartered in Tokyo, Japan. | Private Equity Investor | 2019-10-31 |
Rege Nephro Co. Ltd.
Rege Nephro Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Rege Nephro Co. Ltd. is a company based in Kyoto, Japan that specializes in the research, development, production, and sales of renal disease treatment drugs. The Japanese company has developed a unique and realistic approach to induce high-efficiency differentiation from stem cells, with the aim of saving patients suffering from renal failure. The company's research and development activities focus on developing various solutions for renal disease and improving the quality of life of patients suffering from renal disease. Rege Nephro Co. was founded in 2019 by Kenji Nagafune. | Director/Board Member | - |
Former positions of Akifumi Morinaka
Companies | Position | End |
---|---|---|
CHORDIA THERAPEUTICS INC. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CHORDIA THERAPEUTICS INC. | Health Technology |
Private companies | 2 |
---|---|
JAFCO Group Co. Ltd. (Private Equity)
JAFCO Group Co. Ltd. (Private Equity) Investment ManagersFinance JAFCO Group Co. Ltd. (JAFCO Group) is the private equity arm of the parent firm, JAFCO (TSE: 8595), founded in 1973. The firm is headquartered in Tokyo, Japan. | Finance |
Rege Nephro Co. Ltd.
Rege Nephro Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Rege Nephro Co. Ltd. is a company based in Kyoto, Japan that specializes in the research, development, production, and sales of renal disease treatment drugs. The Japanese company has developed a unique and realistic approach to induce high-efficiency differentiation from stem cells, with the aim of saving patients suffering from renal failure. The company's research and development activities focus on developing various solutions for renal disease and improving the quality of life of patients suffering from renal disease. Rege Nephro Co. was founded in 2019 by Kenji Nagafune. | Commercial Services |
- Stock Market
- Insiders
- Akifumi Morinaka